Showing results (331-340 of 454) with videos related to

Sort By:
Pageof 46
Therapeutic Advances in Gastroenterology|September 2, 2021
Barriers to linkage to care in hepatitis C patients with substance use disorders and dual diagnoses, despite centralized managementLara Grau-López, Cristina Marcos-Fosch, Constanza Daigre, et al.
Hepatology (Baltimore, Md.)|May 13, 2011
Entecavir treatment for chronic hepatitis B: adaptation is not needed for the majority of naïve patients with a partial virological responseRoeland Zoutendijk, Jurriën G P Reijnders, Ashley Brown, et al.
Medicina Clinica|November 9, 2007
[Adefovir dipivoxil compassionate use program in Spain: efficacy and resistance analysis]María Buti, Francisco Rodríguez Frías, José Luis Calleja, et al.
JHEP Reports : Innovation in Hepatology|December 24, 2021
Characterization of the liver immune microenvironment in liver biopsies from patients with chronic HBV infectionNicholas van Buuren, Ricardo Ramirez, Scott Turner, et al.
The New England Journal of Medicine|May 6, 2014
Sofosbuvir and ribavirin in HCV genotypes 2 and 3Stefan Zeuzem, Geoffrey M Dusheiko, Riina Salupere, et al.
Hepatology (Baltimore, Md.)|May 24, 2012
Refinement of stopping rules during treatment of hepatitis C genotype 1 infection with boceprevir and peginterferon/ribavirinIra M Jacobson, Patrick Marcellin, Stefan Zeuzem, et al.
Gut|August 19, 2016
Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis BJulianne Bayliss, Lilly Yuen, Gillian Rosenberg, et al.
Microorganisms|May 25, 2024
In-Host Flat-like Quasispecies: Characterization Methods and Clinical ImplicationsJosep Gregori, Sergi Colomer-Castell, Marta Ibañez-Lligoña, et al.
Hepatology (Baltimore, Md.)|January 30, 2019
JNJ-4178 (AL-335, Odalasvir, and Simeprevir) for 6 or 8 Weeks in Hepatitis C Virus-Infected Patients Without Cirrhosis: OMEGA-1Stefan Zeuzem, Stefan Bourgeois, Susan Greenbloom, et al.
The Journal of Infectious Diseases|April 23, 2020
Hepatitis B Surface Antigen Levels Can Be Used to Rule Out Cirrhosis in Hepatitis B e Antigen-Positive Chronic Hepatitis B: Results From the SONIC-B StudyMilan J Sonneveld, Bettina E Hansen, Willem P Brouwer, et al.
Pageof 46